Back
8 April 2020 Fiftyone Capital Podcasts Time: 14 min and 41 sec podcast
Episode 01: Paradigm Biopharmaceuticals
s one of the first hedge funds to discover the Paradigm story, we have been long term holders and believers in its potential to become a frontline player in the global osteoarthritis market. Here Scott Williams, CIO of FiftyOne Capital details our thoughts on the latest raising, and what we see as the path going forward for this exciting company.
Play:
14 min and 41 sec
